Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Idec receives patent protection for radioimmunotherapy

June 3, 1998

Antisoma and Imperial Cancer Research Technology announce collaboration

May 27, 1998

Glaxo Wellcome's 3622W94: phase I trial results presented at ASCO

May 26, 1998

Pivotal trials of Allovectin-7 begin in advanced metastatic melanoma

May 26, 1998

MDX-210 shows significant antitumor activity in prostate and kidney cancer patients

May 22, 1998

97% response rate for Rituxan + CHOP in small pilot trial in intermediate- or high-grade NHL

May 21, 1998

Favorable preliminary phase I/II trials results reported at ASCO for Titan's cancer vaccines

May 21, 1998

GVAX induces immune responses in prostate cancer patients

May 21, 1998

Herceptin: promising phase III results reported at ASCO

May 20, 1998

Neurocrine Biosciences initiates clinical-stage development of IL-4 fusion toxin

May 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...